Pharmaceutical for treating dizziness having different causes
DE102014118772A1
Dietary supplement in capsule form containing Chinese medicinal mushrooms and their use
AU2013369379A1
Monolithic dosage form for the modified release of an active ingredient combination
DE102012113098A1
Monolithic dosage form, useful in a therapy for treating e.g. pain, psychiatric disorders, cardiovascular diseases, migraine and vertigo of any genesis, comprises first and active ingredients, an emulsifier, and a retarding agent
DE102012105512A1
Pharmaceutical form for prolonged release of active ingredients
DE102012105528A1
Pharmaceutical form for the release of active substances
WO2012150246A1
Dosage form for the controlled release of active ingredients
DE102011053068A1
Dosage form with stabilized active substance particles
DE102011051304A1
drug matrix
DE102011051308A1
Manufacturing process and dosage form
DE102011075354A1
Dosage form comprises at least one first active substance-containing unit, and at least one second active substance-containing unit, and both units comprise a first active substance
DE102005014141A1
Tablet-shaped delayed-release preparation against dizziness
DE102005014142A1
Pellet-shaped delayed-release preparation against dizziness
DE10301981A1
Use of combination of cinnarizin and dimenhydrinate to treat dizziness e.g. caused by inner ear disorders or violent motion
